Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Huperzine a on Presbycusis-related Subjective Tinnitus and Cognitive Impairment

NCT03101722 is registered in ClinicalTrials.gov with Zhijun Bao as lead sponsor.

NCT NCT03101722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03101722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Huperzine a on Presbycusis-related Subjective Tinnitus and Cognitive Impairment
Lead sponsor
Zhijun Bao
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 15, 2017
Completion date
September 15, 2030
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, presbycusis, tinnitus